MedPage Today) — Esketamine nasal spray (Spravato) led to better remission rates compared with extended-release quetiapine (Seroquel XR) in patients with treatment-resistant depression when used in combination with ongoing treatment, the randomized…
Read More
Fakty Miami Top News:
- South Carolina could double as Joe Biden’s coronation and wake-up call
- 12 of the wildest X-planes ever made
- Arterial pulses link heart-brain oscillations | Science
- Envisioning a radical future | Science
- BKFC 57: Best photos from Florida
- Hermon, NY Author Publishes Children’s Book
- Coinbase to list Solana’s BONK, meme coin jumps over 8%
- W QUIZIE historycznym sprawdzamy, ile wiecie o baroku! Macie szanse na 10/10?
Monday, March 18